Zhengwei Cai

Zhengwei Cai

Auto-generated profile, based on publicly available information

Zhengwei Cai

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in ACS Nano
Verified
Journal Article
Closed access
ZZZhenyu Zhao
Zhenyu Zhao
GLGen Li
Gen Li
HRHuitong Ruan
Huitong Ruan
KCKeyi Chen
Keyi Chen
ZCZhengwei Cai
Zhengwei Cai
Wenguo CuiWenguo Cui
Wenguo Cui

1 June 2023 in Biomedical Technology
Verified
Journal Article
Open access
SYShu Yang
Shu Yang
FWFan Wang
Fan Wang
HHHuijie Han
Huijie Han
HSHélder A. Santos
Hélder A. Santos
YZYu Zhang
Yu Zhang
ZCZhengwei Cai
Zhengwei Cai

19 October 2023 in Advanced Science
Verified
Journal Article
Open access
ZCZhijie Chen
Zhijie Chen
MLMengyuan Lv
Mengyuan Lv
JLJing Liang
Jing Liang
KYKai Yang
Kai Yang
FLFan Li
Fan Li
JZJidong Zhang
Jidong Zhang
Postmenopausal osteoporosis (PMO) is often accompanied by neuroendocrine changes in the hypothalamus, which closely associates with the microbial diversity, community composition, and intestinal metabolites of gut microbiota (GM). With the emerging role of GM in bone metabolism, a potential neuroendocrine signal neuropeptide Y (NPY) mediated brain‐gut‐bone axis has come to light. Herein, it is reported that exogenous overexpression of NPY reduced bone formation, damaged bone microstructure, and up‐regulated the expressions of pyroptosis‐related proteins in subchondral cancellous bone in ovariectomized (OVX) rats, but Y1 receptor antagonist (Y1Ra) reversed these changes. In addition, it is found that exogenous overexpression of NPY aggravated colonic inflammation, impaired intestinal barrier integrity, enhanced intestinal permeability, and increased serum lipopolysaccharide (LPS) in OVX rats, and Y1Ra also reversed these changes. Most importantly, NPY and Y1Ra modulated the microbial diversity and changed the community composition of GM in OVX rats, and thereby affecting the metabolites of GM (e.g., LPS) entering the blood circulation. Moreover, fecal microbiota transplantation further testified the effect of NPY‐mediated GM changes on bone. In vitro, LPS induced pyroptosis, reduced viability, and inhibited differentiation of osteoblasts. The study demonstrated the existence of NPY‐mediated brain‐gut‐bone axis and it might be a novel emerging target to treat PMO.

1 December 2020 in Bioactive Materials
Verified
Journal Article
Open access
LCLiang Cheng
Liang Cheng
ZCZhengwei Cai
Zhengwei Cai
JZJingwen Zhao
Jingwen Zhao
FWFei Wang
Fei Wang
MLMin Lu
Min Lu
Wenguo CuiWenguo Cui
Wenguo Cui
Since their discovery, Black Phosphorus (BP)-based nanomaterials have received extensive attentions in the fields of electromechanics, optics and biomedicine, due to their remarkable properties and excellent biocompatibility. The most essential feature of BP is that it is composed of a single phosphorus element, which has a high degree of homology with the inorganic components of natural bone, therefore it has a full advantage in the treatment of bone defects. This review will first introduce the source, physicochemical properties, and degradation products of BP, then introduce the remodeling process of bone, and comprehensively summarize the progress of BP-based materials for bone therapy in the form of hydrogels, polymer membranes, microspheres, and three-dimensional (3D) printed scaffolds. Finally, we discuss the challenges and prospects of BP-based implant materials in bone immune regulation and outlook the future clinical application.

1 January 2024 in Research
Verified
Journal Article
Open access
ZTZixiang Tang
Zixiang Tang
LDLin Deng
Lin Deng
JZJing Zhang
Jing Zhang
TJTao Jiang
Tao Jiang
HXHonglin Xiang
Honglin Xiang
FXfu yong xiong
fu yong xiong
Given the high malignancy of liver cancer and the liver’s unique role in immune and metabolic regulation, current treatments have limited efficacy, resulting in a poor prognosis. Hydrogels, soft 3-dimensional network materials comprising numerous hydrophilic monomers, have considerable potential as intelligent drug delivery systems for liver cancer treatment. The advantages of hydrogels include their versatile delivery modalities, precision targeting, intelligent stimulus response, controlled drug release, high drug loading capacity, excellent slow-release capabilities, and substantial potential as carriers of bioactive molecules. This review presents an in-depth examination of hydrogel-assisted advanced therapies for hepatocellular carcinoma, encompassing small-molecule drug therapy, immunotherapy, gene therapy, and the utilization of other biologics. Furthermore, it examines the integration of hydrogels with conventional liver cancer therapies, including radiation, interventional therapy, and ultrasound. This review provides a comprehensive overview of the numerous advantages of hydrogels and their potential to enhance therapeutic efficacy, targeting, and drug delivery safety. In conclusion, this review addresses the clinical implementation of hydrogels in liver cancer therapy and future challenges and design principles for hydrogel-based systems, and proposes novel research directions and strategies.

1 November 2021 in Chemical Engineering Journal
Verified
Journal Article
Closed access
LZLi Zhao
Li Zhao
FWFei Wang
Fei Wang
ZCZhengwei Cai
Zhengwei Cai
QZQi Zhou
Qi Zhou
BCBo Chen
Bo Chen
ZWZhengting Wang
Zhengting Wang